Showing results 700 to 719 of 3020
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2009 | Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment | Fan, C.; Cool, J.; Scherer, M.; Foster, B.; Shandala, T.; Tapp, H.; Xian, C. |
| 2014 | Day differences in the cortisol awakening response predict day differences in synaptic plasticity in the brain | Clow, A.; Law, R.; Evans, P.; Vallence, A.M.; Hodyl, N.A.; Goldsworthy, M.R.; Rothwell, J.R.; Ridding, M.C. |
| 2016 | De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations | Reijnders, M.; Zachariadis, V.; Latour, B.; Jolly, L.; Mancini, G.; Pfundt, R.; Wu, K.; Van Ravenswaaij-Arts, C.; Veenstra-Knol, H.; Anderlid, B.; Wood, S.; Cheung, S.; Barnicoat, A.; Probst, F.; Magoulas, P.; Brooks, A.; Malmgren, H.; Harila-Saari, A.; Marcelis, C.; Vreeburg, M.; et al. |
| 2004 | De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency | McFarland, R.; Kirby, D.; Fowler, K.; Ohtake, A.; Ryan, M.; Amor, D.; Fletcher, J.; Dixon, J.; Collins, F.; Turnbull, D.; Taylor, R.; Thorburn, A. |
| 2010 | De novo mutations of SETBP1 cause Schinzel-Giedion syndrome | Hoischen, A.; Van Bon, B.; Gilissen, C.; Arts, P.; van Lier, B.; Steehouwer, M.; de Vries, P.; de Reuver, R.; Wieskamp, N.; Mortier, G.; Devriendt, K.; Amorim, M.; Revencu, N.; Kidd, A.; Barbosa, M.; Turner, A.; Smith, J.; Olay, C.; Henderson, A.; Hayes, I.; et al. |
| 2010 | De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin | Heron, S.; Scheffer, I.; Iona, X.; Zuberi, S.; Birch, R.; McMahon, J.; Bruce, C.; Berkovic, S.; Mulley, J. |
| 2011 | De novo SCN1A mutations in migrating partial seizures of infancy | Carranza Rojo, D.; Hamiwka, L.; McMahon, J.; Dibbens, L.; Arsov, T.; Suls, A.; Stodberg, T.; Kelley, K.; Wirrell, E.; Appleton, B.; Mackay, M.; Freeman, J.; Yendle, S.; Berkovic, S.; Bienvenu, T.; De Jonghe, P.; Thorburn, D.; Mulley, J.; Mefford, H.; Scheffer, I. |
| 2015 | Dealing with the unknown: reducing the proportion of unvalidated treatments offered to children | Wilkinson, D.; Chalmers, I.; Cruz, M.; Tarnow-Mordi, W. |
| 2016 | Death talk: Basic linguistic rules and communication in perinatal and paediatric end-of-life discussions | Xafis, V.; Watkins, A.; Wilkinson, D. |
| 2013 | Debate: idiopathic short stature should be treated with growth hormone | Ambler, G.; Fairchild, J.; Wilkinson, D. |
| 2011 | Decreased expression of Flightless I, a gelsolin family member and developmental regulator, in early-gestation fetal wounds improves healing | Lin, C.; Waters, J.; Powell, B.; Arkell, R.; Cowin, A. |
| 2013 | Decreased insulin sensitivity in young adults born through in vitro fertilisation (IVF) and higher systolic blood pressure following high fat overfeeding | Chen, M.; Zhao, J.; Davies, M.J.; Wittert, G.A.; Norman, R.J.; Heilbronn, L.K.; International Federation of Fertility Societies 21st World Congress on Fertility and Sterility and the 69th Annual Meeting of the American Society for Reproductive Medicine (12 Oct 2013 - 17 Oct 2013 : Boston, MA) |
| 2017 | Defining a set of common interprofessional learning competencies for health profession students | O’Keefe, M.; Henderson, A.; Chick, R. |
| 2002 | Defining regions of loss of heterozygosity of 16q in breast cancer cell lines | Callen, D.; Crawford, J.; Derwas, C.; Cleton-Jansen, A.; Cornelisse, C.; Baker, E. |
| 2006 | Defining the dosage units for colistin methanesulfonate: Urgent need for international harmonization | Li, J.; Nation, R.; Turnidge, J. |
| 1995 | Degradation of IGF-1 in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein | Xian, C.; Shoubridge, C.; Read, L. |
| 2008 | Deletion of Glu155 causes a deficiency of glutathione transferase Omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs | Schmuck, E.; Cappello, J.; Coggan, M.; Brew, J.; Cavanaugh, J.; Blackburn, A.; Baker, R.; Eyre, H.; Sutherland, G.; Board, P. |
| 2009 | Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases | Hemsley, K.; Hopwood, J. |
| 2006 | delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha 4 beta 2 delta GABA(A) receptors | Feng, H.; Kang, J.; Song, L.; Dibbens, L.; Mulley, J.; Macdonald, R. |
| 2001 | Depression among Australian adolescents | Rey, J.; Sawyer, M.; Clark, J.; Baghurst, P. |
